Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS
10:56am, Wednesday, 04'th Mar 2026
Moderna jumps after $2.25B settlement with Genevant and Arbutus over LNP patents tied to its COVID-19 and RSV vaccines, ending global litigation.
Moderna to pay up to $2.25B to settle COVID vaccine patent matter
10:20am, Wednesday, 04'th Mar 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock added almost 9% after it was announced that the drugmaker has agreed to pay up to $2.25 billion to settle a global patent infringement lawsuit brought by Arb
2 High-Flying Stocks With More Upside to Buy and Hold
09:12am, Wednesday, 04'th Mar 2026
Walmart is expertly navigating a challenging retail environment while continuing to grow its dividend. Moderna has a promising candidate that could hit the market in the near future.
Stock Futures Boosted by Middle East Headlines
09:11am, Wednesday, 04'th Mar 2026
Stocks are in rally mode today, as developments in the Middle East indicate oil price relief and an end to the conflict
Moderna and Ross Stores Lead Stock Gainers on Wednesday
08:40am, Wednesday, 04'th Mar 2026
Two stocks are standing out in premarket trading this Wednesday morning. Moderna (Nasdaq: MRNA) is up 8.9% and Ross Stores (Nasdaq: ROSS) is up 6.6% as of 8:00 AM ET, each moving on a distinct cataly
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
08:26am, Wednesday, 04'th Mar 2026
Moderna shares rose 10% in premarket trading on Wednesday after the company settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, removing an overhang and
Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars
08:14am, Wednesday, 04'th Mar 2026
Moderna Inc. (NASDAQ: MRNA) shares are up during Wednesday's premarket session following a settlement agreement with Arbutus Biopharma Corporation (NASDAQ: ABUS) and Roivant Inc.'s (NASDAQ: ROIV) Gene
First Look: Target (TGT), Paramount (PSKY) and Gold in Focus
07:38am, Wednesday, 04'th Mar 2026
Stock News Wall Street whipsawed by Mideast turmoil: The SPDR S&P 500 ETF Trust (SPY) fell Tuesday, then futures steadied as oil volatility and safeâhaven flo
Moderna Stock Rallies. This Big Risk Just Got Eliminated.
05:25am, Wednesday, 04'th Mar 2026
The company settles to resove patent litigation related to its Covid-19 vaccine, removing an overhang for shares.
Moderna Pops After Inking $950 Million Covid Vaccine Settlement
06:23pm, Tuesday, 03'rd Mar 2026
Moderna settled a yearslong patent dispute with Arbutus Biopharma and a subsidiary of Roivant Sciences. The news sent Moderna shares jumping.
Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline
05:30pm, Tuesday, 03'rd Mar 2026
The deal would provide ‘certainty' for Moderna's vaccine portfolio.
Moderna Stock Jumps 10% After Hours: Here's Why
04:55pm, Tuesday, 03'rd Mar 2026
Moderna shares are rising in Tuesday's after-hours session after the company announced it reached a settlement agreement.
Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant
04:46pm, Tuesday, 03'rd Mar 2026
The company will appeal to a federal circuit court to argue that it has limited liability due to its status as a government contractor.
Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute
04:26pm, Tuesday, 03'rd Mar 2026
Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences , and Arbutus Biopharma up to $2.25 billion to settle a long-running legal fight over the technology
Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
04:22pm, Tuesday, 03'rd Mar 2026
Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
